Prediction of deterioration of mild cognitive impairment with CT and SPECT

Tomasz Gabryelewicz1, Agnieszka Pawłowska-Detko, Jolanta Miśko

  • 1Department of Neurodegenerative Disorders, Medical Research Center, Polish Academy of Sciences, Warsaw, Poland. gabryelewicz@cmdik.pan.pl <gabryelewicz@cmdik.pan.pl>

Abstract

Insights

Mild cognitive impairment (MCI) patients with specific brain structure changes at baseline are more likely to progress. These CT-based measurements may predict cognitive decline in MCI individuals.

Area of Science:

  • Neurology
  • Neuroimaging
  • Cognitive Science

Background:

  • Mild cognitive impairment (MCI) involves memory deficits and functional impairments, increasing dementia risk.
  • Distinguishing MCI patients who will progress from those who remain stable is crucial for early intervention.
  • This study investigated baseline neuroimaging and cognitive differences in MCI subjects based on their progression over time.

Purpose of the Study:

  • To identify baseline neuroimaging and cognitive predictors of cognitive deterioration in individuals with MCI.
  • To compare neuroimaging markers between MCI patients who remained stable and those who progressed over a three-year follow-up period.

Main Methods:

  • 105 individuals diagnosed with MCI underwent annual clinical and psychometric evaluations for up to three years.
  • Baseline neuroimaging included temporal lobe-oriented CT scans and 99mTc HMPAO SPECT.
  • MCI diagnosis followed Mayo Clinic Petersen's Criteria, with comprehensive neuropsychological testing.

Main Results:

  • Of 105 MCI subjects, 63 showed cognitive decline, with 23 converting to dementia within three years.
  • Progressing MCI patients exhibited significantly greater temporal horn width, wider right transverse fissure, a dilated third ventricle, and thinner hippocampi at baseline compared to stable patients.
  • No significant differences in brain perfusion (SPECT) were observed between the groups.

Conclusions:

  • Linear measurements of brain atrophy on CT scans at baseline can predict which MCI patients are more likely to deteriorate.
  • CT-based morphometric analysis offers a potential tool for identifying MCI individuals at higher risk for progression to dementia.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...